ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the H.C. Wainwright Bioconnect Conference as follows:
Date: |
Monday, January 10, 2022 |
||||
On Demand: |
7:00 a.m. ET |
||||
Webcast: |
https://journey.ct.events/view/5e7687b5-9c3a-4a19-b96c-88ad184d5c59 |
The webcast will be accessible on demand beginning on January 10, 2022, at 7:00 a.m. ET and archived for 90 days thereafter, via the Company’s website at www.anipharmaceuticals.com, under the Investors section.
About ANI
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin™ Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
Contacts
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Media:
Angela Salerno-Robin
dna Communications
T: 212-445-8219
E: ASalerno-Robin@dna-comms.com
Editor Details
-
Company:
- Businesswire
